Products for Research Use Only

5-Bromonicotinic acid

CAT: 0804-HY-Y1013-01Size: 100 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-Y1013-01Size:100 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
5-Bromonicotinic acid can be used as a pharmaceutical intermediate to synthesize 5-aryloyl nicotinic acid compounds. 5-Bromonicotinic acid has the characteristics of good drug similarity, high oral bioavailability, and low toxicity through molecular docking prediction. 5-Bromonicotinic acid has good binding ability with hepatitis virus proteins (binding energy: -4.7 to -5.3 kcal/mol) [1][2].
CAS Number
20826-04-4
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H335
Target
Drug Intermediate
Type
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/5-bromonicotinic-acid.html
Purity
99.83
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(Br)=CN=C1)O
Molecular Formula
C6H4BrNO2
Molecular Weight
202.01
Precautions
H302, H315, H319, H335
References & Citations
[1]Wang A, et al. Investigation of the reaction of 5-bromonicotinic acid with certain arylacetonitriles and LDA in THF[J]. Heterocycles, 1997, 45 (10) : 1929-1935. |[2]R S, et al. Structural, electronic, intermolecular interaction, reactivity, vibrational spectroscopy, charge transfer, Hirshfeld surface analysis, pharmacological and hydropathy plot on 5-Bromo nicotinic acid - Antiviral study (Hepatitis A, B, and C) . Heliyon. 2023 Sep 7;9 (9) :e19965.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported